Webinar Tumor growth modeling with MonolixSuite - Session 2
发布人
打开封面 下载高清视频 观看高清视频 视频下载器
...
Webinar QSP modeling with MonolixSuite - Session 1
...
Webinar Tumor growth modeling with MonolixSuite - Session 1
...
Webinar QSP modeling with MonolixSuite - Session 2
...
Concentration-QTc modeling with MonolixSuite
...
Modeling of Remifentanil's pharmacokinetics using MonolixSuite
...
Modeling double peaks in plasma concentrations of veralipride
...
Time-to-event modeling with MonolixSuite with a case study on lung cancer surviv
...
Case study PK modeling workflow on warfarin with Monolix Suite 2018
...
《如何设计IND申报中的DMPK研究内容》（1）
...
Case study PKPD modeling using the simultaneous, sequential or intermediate appr
...
vet（二）
...
创新药转化PK/PD研究与首次人体试验的剂量设计
...
Monolix 2019R1_ overview
...
Sycomore 2019R1 Overview & management of Monolix runs
...
猫口炎的诊断和治疗
...
vet123（一）
...
Communicating to Influence Drug Development and Regulatory Decisions A Tutorial
...
《如何设计IND申报中的DMPK研究内容》（2）
...
Application of MIDD in New Drug Development 王亚宁
...
新形势下我国新药I期临床试验现状、机遇和挑战
...
Case study Inter-occasion variability and effect of guar gum on alcohol concentr
...
液质联用技术在靶向代谢组学中的研究进展20211230
...
Mini case study Calculating PKPD parameters for an antibiotic
...
Case study Implementing a proportional hazard model and calculating hazard ratio
...
十三分鐘略懂 AI 技術：機器學習、深度學習技術原理及延伸應用
...
Lecture 1.1 Introduction to pharmacokinetics
...
Case study PK model development for a multi-dose study (Maryland 2)
...
FDA群体药代动力学行业指导原则解析
...
Case study PK model development and covariate exploration (Maryland 1)
...
疫情常态化下的在线教学与混合式教学设计
...
Lecture 1.4 Pharmacokinetic Models
...
Communicating to Influence Drug Development and Regulatory Decisions A (2)
...
Lecture 1.3 Therapeutic window
...
Mini case study time-varying clearance
...
ISQP主会场20211205
...
Mini case study #4 Understanding flip-flop kinetics
...
Mini case-study #2 Implementing a model with dose-dependent bioavailability
...
生物技术药物免疫原性和药代方法学建设
...
Mini case study #3 Writing a model for urine data
...
PKanalix 2019R1_ NCA & CA analysis